From January 1, 2023 to March 31, 2023, the company has repurchased 3,618,461 shares, representing 0.94% for $525.8 million. With this, the company has completed the repurchase of 5,099,847 shares, representing 1.32% for $711.82 million under the buyback announced on August 3, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.2 USD | -2.45% | +4.10% | +6.77% |
Apr. 24 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
Apr. 24 | Moderna to Collaborate With OpenAI to Launch New Generation of Medicines | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.77% | 41.68B | |
+1.12% | 43.84B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B | |
-18.79% | 9.98B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Tranche Update on Moderna, Inc.'s Equity Buyback Plan announced on August 3, 2022.